Literature DB >> 3598671

Long-term prospective study of lumbosacral discectomy.

P J Lewis, B K Weir, R W Broad, M G Grace.   

Abstract

A long-term prospective study of 100 patients undergoing lumbosacral discectomy was carried out in an attempt to delineate the natural history of these patients and to assess the relative significance of preoperative factors as determinants of long-term outcome. Neurological findings were documented preoperatively and at 1 month, 1 year, and 5 to 10 years postoperatively. A questionnaire using subjective and objective data was given to patients at 1 year and 5 to 10 years postoperatively. An 83% long-term follow-up result was obtained. At a minimum of 5 years postoperatively, 62% of patients had complete relief of back pain and 62% had complete relief of leg pain; 96% were pleased that they had submitted to surgery and 93% were able to return to work. Nine percent reported that their back pain at 5 to 10 years was as severe as or worse than preoperatively and 11% reported that their leg pain was as severe as or worse than preoperatively. The reoperation rate was 18%. Preoperative factors found to be significantly associated with outcome at 1 year postoperatively were not significantly associated with outcome at 5 to 10 years postoperatively. The results of lumbosacral discectomy appear favorable as evaluated in this study. Preoperative factors useful as predictors of short-term outcome are much less reliable when considering the long-term results.

Entities:  

Mesh:

Year:  1987        PMID: 3598671     DOI: 10.3171/jns.1987.67.1.0049

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  30 in total

1.  Chemonucleolysis versus surgical discectomy for sciatica secondary to lumbar disc herniation. A cost and quality-of-life evaluation.

Authors:  R Launois; B Henry; J R Marty; M Gersberg; C Lassale; M Benoist; J M Goehrs
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

2.  Endoscopic transforaminal suprapedicular approach in high grade inferior migrated lumbar disc herniation.

Authors:  Hyeun Sung Kim; Chang Il Ju; Seok Won Kim; Jong Gue Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-02-28

3.  Strategies for Noncontained Lumbar Disc Herniation by an Endoscopic Approach : Transforaminal Suprapedicular Approach, Semi-Rigid Flexible Curved Probe, and 3-Dimensional Reconstruction CT with Discogram.

Authors:  Ki Hwan Chae; Chang Il Ju; Seung Myung Lee; Byoung Wook Kim; Saeng Youp Kim; Hyeun Sung Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-10-31

4.  Does the choice of outcome scale influence prognostic factors for lumbar disc surgery? A prospective, consecutive study of 121 patients.

Authors:  C Woertgen; M Holzschuh; R D Rothoerl; A Brawanski
Journal:  Eur Spine J       Date:  1997       Impact factor: 3.134

5.  Cost-effectiveness of percutaneous automated lumbar nucleotomy. Comparison with traditional macro-procedure discectomy.

Authors:  R Dullerud; H Lie; B Magnæs
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

6.  Risk factors of recurrent disc herniation.

Authors:  C Reith; G Lausberg
Journal:  Neurosurg Rev       Date:  1989       Impact factor: 3.042

7.  Surgery for herniated lumbar discs: a literature synthesis.

Authors:  R M Hoffman; K J Wheeler; R A Deyo
Journal:  J Gen Intern Med       Date:  1993-09       Impact factor: 5.128

8.  Lumbar disc herniation in teenagers.

Authors:  L Ferrante; L Mastronardi; P Lunardi; F Puzzilli; A Fortuna
Journal:  Eur Spine J       Date:  1992-06       Impact factor: 3.134

9.  Huge Psoas Muscle Hematoma due to Lumbar Segmental Vessel Injury Following Percutaneous Endoscopic Lumbar Discectomy.

Authors:  Hyeun Sung Kim; Chang Il Ju; Seok Won Kim; Jong Gue Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-03-31

10.  The risk of "getting worse" after lumbar microdiscectomy.

Authors:  Tore K Solberg; Oystein P Nygaard; Kristin Sjaavik; Dag Hofoss; Tor Ingebrigtsen
Journal:  Eur Spine J       Date:  2004-05-06       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.